Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor

Clinical trial NCT06105021 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06105021
Sponsor: Affini-T Therapeutics, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma Non-Small Cell Lung Cancer Colorectal Cancer Solid Tumor KRAS G12V

Start date: 2024-03-06
Primary completion: 2025-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.